共 50 条
- [47] Real-world analysis of patient characteristics, treatment outcomes, and healthcare resource utilization across Europe in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation who received lenalidomide- or bortezomib-based regimens [J]. LEUKEMIA & LYMPHOMA, 2021, 62 (10) : 2492 - 2501